Terms: = Head and neck cancer AND TCF3, E2A, 6929, ENSG00000071564, P15923, MGC129648, MGC129647, ITF1 AND Treatment
4 results:
1. HSP40 co-chaperone protein Tid1 suppresses metastasis of head and neck cancer by inhibiting Galectin-7-tcf3-MMP9 axis signaling.
Chen YS; Chang CW; Tsay YG; Huang LY; Wu YC; Cheng LH; Yang CC; Wu CH; Teo WH; Hung KF; Huang CY; Lee TC; Lo JF
Theranostics; 2018; 8(14):3841-3855. PubMed ID: 30083263
[TBL] [Abstract] [Full Text] [Related]
2. Development and Validation of a Gene Signature for Patients with head and neck Carcinomas Treated by Postoperative Radio(chemo)therapy.
Schmidt S; Linge A; Zwanenburg A; Leger S; Lohaus F; Krenn C; Appold S; Gudziol V; Nowak A; von Neubeck C; Tinhofer I; Budach V; Sak A; Stuschke M; Balermpas P; Rödel C; Bunea H; Grosu AL; Abdollahi A; Debus J; Ganswindt U; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baretton GB; Buchholz F; Baumann M; Krause M; Löck S;
Clin Cancer Res; 2018 Mar; 24(6):1364-1374. PubMed ID: 29298797
[No Abstract] [Full Text] [Related]
3. The increased expression of tcf3 is correlated with poor prognosis in Chinese patients with nasopharyngeal carcinoma.
Shen X; Yuan J; Zhang M; Li W; Ni B; Wu Y; Jiang L; Fan W; Tian Z
Clin Otolaryngol; 2017 Aug; 42(4):824-830. PubMed ID: 28107608
[TBL] [Abstract] [Full Text] [Related]
4. Association between plasma proteome profiles analysed by mass spectrometry, a lymphocyte-based DNA-break repair assay and radiotherapy-induced acute mucosal reaction in head and neck cancer patients.
Pietrowska M; Polańska J; Walaszczyk A; Wygoda A; Rutkowski T; Składowski K; Marczak L; Stobiecki M; Marczyk M; Polański A; Widłak P
Int J Radiat Biol; 2011 Jul; 87(7):711-9. PubMed ID: 21351848
[TBL] [Abstract] [Full Text] [Related]
